Bad Elsevier, the story

Yesterday, I posted about Elsevier being on the take in a scheme by Merck to publish a fake peer-reviewed journal. Today, the blog Drug Injury Watch has more of the story:
Elsevier acknowledged that Merck had sponsored the publication, but did not disclose the amount the drug company paid. In a statement emailed to The Scientist, Elsevier said that the company "does not today consider a compilation of reprinted articles a 'Journal'."

"Elsevier acknowledges the concern that the journals in question didn't have the appropriate disclosures," the statement continued. "It is worth noting that project in question was produced 6 years ago and disclosure protocols have evolved since 2003. Elsevier's current disclosure policies meet the rigor and requirements of the current publishing environment."

No comments:

Post a Comment